![]() |
VOOZH | about |
*601953
Table of Contents
Alternative titles; symbols
HGNC Approved Gene Symbol: CCNH
Cytogenetic location: 5q14.3 Genomic coordinates (GRCh38) : 5:87,311,471-87,412,930 (from NCBI)
The cdk-activating kinase (CAK) is a multi-subunit protein which phosphorylates and thus activates certain cyclin-dependent protein kinases in the regulation of cell cycle progression. Fisher and Morgan (1994) purified mammalian CAK and found that it was composed of 2 major polypeptides, a 37-kD cyclin termed cyclin H and a 42-kD cyclin-dependent kinase (CDK7; 601955). Fisher and Morgan (1994) cloned the cyclin H gene encoding a 323-amino acid polypeptide homologous to STK1 (CDK7) and Xenopus MO15, a cell cycle-associated kinase. The authors reported that a reconstituted cyclin H/CDK7 complex was able to phosphorylate CDK2 (116953) and CDC2 (116940) in vitro.
Shiekhattar et al. (1995) purified transcription factor IIH (TFIIH; see 189972) and found that it contained material that reacted with antibodies to CDK7 and cyclin H. The authors confirmed the presence of the CAK complex as a distinct component of TFIIH, suggesting a link between TFIIH (by the phosphorylation of CDC2 or CDK2) and the processes of transcription, DNA repair, and cell cycle progression.
Mammalian CDK8 (603184) and cyclin C (123838) are components of the RNA polymerase II holoenzyme complex, where they function as a protein kinase that phosphorylates the C-terminal domain of the largest subunit of RNA polymerase II. The CDK8/cyclin C protein complex is also found in a number of mammalian 'Mediator'-like protein complexes, which repress activated transcription independently of the C-terminal domain in vitro. Akoulitchev et al. (2000) demonstrated that CDK8/cyclin C can regulate transcription by targeting the CDK7/cyclin H subunits of TFIIH. CDK8 phosphorylates mammalian cyclin H at serine-5 and serine-304 both in vitro and in vivo, in the vicinity of its functionally unique N- and C-terminal alpha-helical domains. This phosphorylation represses both the ability of TFIIH to activate transcription and its C-terminal kinase activity. In addition, mimicking CDK8 phosphorylation of cyclin H in vivo has a dominant-negative effect on cell growth. Akoulitchev et al. (2000) concluded that their results linked the Mediator complex and the basal transcription machinery by a regulatory pathway involving 2 cyclin-dependent kinases. This pathway appears to be unique to higher organisms.
Andersen et al. (1996) found the crystal structure of cyclin H to be similar to the structure of cyclin A (123835), both containing the canonical cyclin fold.
Eki et al. (1998) used somatic cell hybrid panels, fluorescence in situ hybridization, and YAC contigs to map the cyclin H gene to human chromosome 5q13.3-q14.
Akoulitchev, S., Chuikov, S., Reinberg, D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407: 102-106, 2000. [PubMed: 10993082, related citations] [Full Text]
Andersen, G., Poterszman, A., Egly, J. M., Moras, D., Thierry, J.-C. The crystal structure of human cyclin H. FEBS Lett. 397: 65-69, 1996. [PubMed: 8941715, related citations] [Full Text]
Eki, T., Okumura, K., Abe, M., Kagotani, K., Taguchi, H., Murakami, Y., Pan, Z.-Q., Hanaoka, F. Mapping of the human genes encoding cyclin H (CCNH) and the CDK-activating kinase (CAK) assembly factor MAT1 (MNAT1) to chromosome bands 5q13.3-q14 and 14q23, respectively. Genomics 47: 115-120, 1998. [PubMed: 9465303, related citations] [Full Text]
Fisher, R. P., Morgan, D. O. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78: 713-724, 1994. [PubMed: 8069918, related citations] [Full Text]
Shiekhattar, R., Mermelstein, F., Fisher, R. P., Drapkin, R., Dynlacht, B., Wessling, H. C., Morgan, D. O., Reinberg, D. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374: 283-287, 1995. [PubMed: 7533895, related citations] [Full Text]
Alternative titles; symbols
HGNC Approved Gene Symbol: CCNH
Cytogenetic location: 5q14.3 Genomic coordinates (GRCh38) : 5:87,311,471-87,412,930 (from NCBI)
The cdk-activating kinase (CAK) is a multi-subunit protein which phosphorylates and thus activates certain cyclin-dependent protein kinases in the regulation of cell cycle progression. Fisher and Morgan (1994) purified mammalian CAK and found that it was composed of 2 major polypeptides, a 37-kD cyclin termed cyclin H and a 42-kD cyclin-dependent kinase (CDK7; 601955). Fisher and Morgan (1994) cloned the cyclin H gene encoding a 323-amino acid polypeptide homologous to STK1 (CDK7) and Xenopus MO15, a cell cycle-associated kinase. The authors reported that a reconstituted cyclin H/CDK7 complex was able to phosphorylate CDK2 (116953) and CDC2 (116940) in vitro.
Shiekhattar et al. (1995) purified transcription factor IIH (TFIIH; see 189972) and found that it contained material that reacted with antibodies to CDK7 and cyclin H. The authors confirmed the presence of the CAK complex as a distinct component of TFIIH, suggesting a link between TFIIH (by the phosphorylation of CDC2 or CDK2) and the processes of transcription, DNA repair, and cell cycle progression.
Mammalian CDK8 (603184) and cyclin C (123838) are components of the RNA polymerase II holoenzyme complex, where they function as a protein kinase that phosphorylates the C-terminal domain of the largest subunit of RNA polymerase II. The CDK8/cyclin C protein complex is also found in a number of mammalian 'Mediator'-like protein complexes, which repress activated transcription independently of the C-terminal domain in vitro. Akoulitchev et al. (2000) demonstrated that CDK8/cyclin C can regulate transcription by targeting the CDK7/cyclin H subunits of TFIIH. CDK8 phosphorylates mammalian cyclin H at serine-5 and serine-304 both in vitro and in vivo, in the vicinity of its functionally unique N- and C-terminal alpha-helical domains. This phosphorylation represses both the ability of TFIIH to activate transcription and its C-terminal kinase activity. In addition, mimicking CDK8 phosphorylation of cyclin H in vivo has a dominant-negative effect on cell growth. Akoulitchev et al. (2000) concluded that their results linked the Mediator complex and the basal transcription machinery by a regulatory pathway involving 2 cyclin-dependent kinases. This pathway appears to be unique to higher organisms.
Andersen et al. (1996) found the crystal structure of cyclin H to be similar to the structure of cyclin A (123835), both containing the canonical cyclin fold.
Eki et al. (1998) used somatic cell hybrid panels, fluorescence in situ hybridization, and YAC contigs to map the cyclin H gene to human chromosome 5q13.3-q14.
Akoulitchev, S., Chuikov, S., Reinberg, D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407: 102-106, 2000. [PubMed: 10993082] [Full Text: https://doi.org/10.1038/35024111]
Andersen, G., Poterszman, A., Egly, J. M., Moras, D., Thierry, J.-C. The crystal structure of human cyclin H. FEBS Lett. 397: 65-69, 1996. [PubMed: 8941715] [Full Text: https://doi.org/10.1016/s0014-5793(96)01143-x]
Eki, T., Okumura, K., Abe, M., Kagotani, K., Taguchi, H., Murakami, Y., Pan, Z.-Q., Hanaoka, F. Mapping of the human genes encoding cyclin H (CCNH) and the CDK-activating kinase (CAK) assembly factor MAT1 (MNAT1) to chromosome bands 5q13.3-q14 and 14q23, respectively. Genomics 47: 115-120, 1998. [PubMed: 9465303] [Full Text: https://doi.org/10.1006/geno.1997.5053]
Fisher, R. P., Morgan, D. O. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78: 713-724, 1994. [PubMed: 8069918] [Full Text: https://doi.org/10.1016/0092-8674(94)90535-5]
Shiekhattar, R., Mermelstein, F., Fisher, R. P., Drapkin, R., Dynlacht, B., Wessling, H. C., Morgan, D. O., Reinberg, D. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374: 283-287, 1995. [PubMed: 7533895] [Full Text: https://doi.org/10.1038/374283a0]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM